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Long-term Functional Outcomes of Brachio-Basilic
Arterio-Venous Fistulas
Casey Yossa, Dean Healy, Satish Muluk. Cardiovascular &
Thoracic Surgery, West Penn Allegheny Health System,
Pittsburgh, PA
Objectives: According to NKF-DOQI guidelines, bra-
chiobasilic fistulas (bbfs) are the next best alternative if a
radio- or brachio-cephalic fistula cannot be successfully
created. However, there are few current, large series in the
literature examining their outcomes. Our objective was to
review our experience with bbfs, including the factors af-
fecting functional patency.
Methods: We reviewed 134 consecutive bbfs per-
formed over a period of 5 years. We recorded demograph-
ics, comorbidities, time to access, and functional patency.
Data were analyzed by chi-square, life-table, and propor-
tional hazards modeling.
Results: 15 patients were either lost to initial follow up
(n6), died (n8), or received transplant (n1) before
dialysis was attempted. Among the remaining 119, mean
follow-up was 22months. Three bbfs were ligated early due
to steal and 25 failed to mature. 91 bbfs (76%) matured to
successful dialysis. Of these, median time to first access was
6 weeks (mean 6.4 weeks). By life-table analysis, median
functional primary patency was 41 months, while median
primary assisted patency was 49 months. The only signifi-
cant factor predicting increased primary patency was female
gender (figure).
Diabetic patients exhibited a non-significant trend toward
shorter patency. BMI, age, and smoking were not predic-
tors of time to failure.
Conclusions:This large series shows that bbfs can yield
acceptable long-term functional outcomes with maturation
rates higher than those generally reported for forearm
fistulas. The procedure appears to be especially valuable in
females, and outcomes are not adversely affected by ele-
vated age or BMI.
Author Disclosures: D. Healy: Nothing to disclose; S.
Muluk: Nothing to disclose; C. Yossa: Nothing to dis-
close.
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Norman M. Rich Award
Microvascular Porcine Model for the Optimization of
Composite Tissue AutoTransplantation
Carole Villamaria, Todd Rasmussen, Jerry Spencer,
Michael Davis. US Army Institute of Surgical Research, Ft.
Sam Houston, TX
Introduction: Devastating extremity injuries are prev-
alent on the modern battlefield. Improved body armor,
rapid evacuation times and advanced critical care yield
survivability in the face of catastrophic limb trauma. The
number and complexity of these injuries requires novel
methods for salvage and reconstruction. This model is de-
signed to assess the solution H2S for its ability to optimize
tissue stability and viability during composite tissue transplan-
tation and thus expand reconstruction applications.
Methods: A donor gracilis myocutaneous flap with its
associated Mathes type II arteriovenous axis is procured
from 70-90kg Yorkshire swine. Utilizing the right external
carotid artery and internal jugular vein as the recipient axis,
microvasular anastamosis is performed. Control group 1
undergoes immediate microvascular anastamosis with re-
sultant 1 hour ischemic period with interim perfusion with
heparinized saline. Control group 2 undergoes delayed
anastamosis with 3 hour ischemic period and interim per-
fusion with heparinized saline. These are compared with
experimental group I which undergoes interim perfusion
with H2S for 1 hour and experimental group 2 which
undergoes interim perfusion with H2S for 3 hours. Mark-
ers of ischemia-reperfusion injury are evaluated following
anastamosis and on POD#1, 2, 7 and 14.
Results: This porcine microvascular model has been
validated and control animals accomplished. The standard
degree of ischemia-reperfusion injury has been established
in the controls with laboratory and histologic analysis.
Experimental groups are now underway.
Conclusions: We have established and validated a
novel porcine model for microvascular composite tissue
transplantation. This model will be utilized to assess the
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effects of H2S on tissue stability and viability, and opti-
mize conditions for transplantation and for the eventual
induction of immunotolerance to composite tissue
allotransplants.
Author Disclosures: C. Villamaria, Nothing to disclose;
T. Rasmussen: Nothing to disclose; J. Spencer, Nothing
to disclose M. Davis, Nothing to disclose.
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Should Endovenous Ablation of Small Diameter Great
Saphenous Veins Be Performed on Patients with Symp-
tomatic Varicose Veins?
Steven Perrins, Andrew Cha, Dahlia Plummer, Richard
Hsu, Alan M. Dietzek. Surgery, Danbury Hospital, Dan-
bury, CT
Objectives: The efficacy of radiofrequency ablation
(RFA) for symptomatic varicose veins is well established.
Alternatively, there is less consensus and little data on
outcomes when treating great saphenous veins (GSV) of
small diameter (5mm). To this point, there are national
insurance carriers that deny coverage for endovenous abla-
tion for patients with small GSV citing lack of proven
benefit. The purpose of this study is to assess clinical and
anatomical outcomes of RFA on small diameter, symptom-
atic GSV at 3 months.
Methods: A retrospective analysis was performed of
our patients who received RFA of incompetent GSV with-
out any concomitant adjunctive procedures between Janu-
ary 2008 and December 2011. Limbs with a maximum
GSV thigh diameter5mm on duplex while standing were
subject to review. Clinical success was defined as an im-
provement in Venous Clinical Severity Score (VCSS) at 3
months. Anatomic success was defined as absence of venous
flow 3cm distal to the saphenofemoral junction (SFJ) on
duplex ultrasound examination. Changes in CEAP class
were noted.
Results: In 307 patients, 54 limbs in 44 patients met
inclusion criteria. Baseline median VCSS was 4 (interquar-
tile range 4, 5). Clinical success was seen in 83% of limbs at 3
months with amedianVCSS change of -2 (IQR -3, -1).None
of the treated limbs had phlebectomy for symptomatic vari-
cosities prior to 3 month follow-up. One phlebectomy was
performed for cosmesis at 78 days post procedure. Anatomic
success was achieved in 96% of limbs at 3 months. Baseline
medianCEAPwas 2 (IQR2, 2). ThemedianCEAPchange at
3 months was 0 (IQR -1, 0).The only complication was a
thrombus extension into the SFJ at 4 days.
Conclusions: In our experience, RFA of symptomatic
small diameter GSV provides comparable clinical and ana-
tomic outcomes to that of current published data. Our
findings suggest that these patients benefit clinically from
the RFA procedure and should not be denied this treat-
ment based upon vessel diameter alone.
Author Disclosures: A. Cha: Nothing to disclose; A. M.
Dietzek: Covidien,Speaker’s bureau; R. Hsu: Nothing to
disclose; S. Perrins: Nothing to disclose; D. Plummer:
Nothing to disclose.
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Implementation of the Screen for Abdominal Aortic
Aneurysms Very Efficiently (SAAAVE) Act: A Five-
Year Follow-up
Kevin C. Chun, Kai Y. Teng, Elyse N. Van Spyk, John G.
Carson, Eugene S. Lee. University of California, Davis and
Sacramento VA Medical Center; Sacramento, CA
Objectives: In 2007, Medicare guidelines were estab-
lished to identify persons at risk for the presence of an
abdominal aortic aneurysm (AAA). The purpose of this
study was to evaluate the implementation of the SAAAVE
Act in identifying patients at risk for AAA within a 5-year
period in clinical practice.
Methods: Data was extracted from a regional Veterans
Affairs Healthcare Network to identify all veteran males
65-75 years of age who smoked greater than 100 cigarettes
during their lifetime. In 2007, a AAA screening mandate
was implemented allowing patients meeting screening cri-
teria to be evaluated for AAA as part of the patient’s health
maintenance. AAA is identified as an aortic diameter size of
3.0 cm or greater. Clinician adherence to screening proto-
cols and timely referral for aneurysms greater than 5.5 cm
were also evaluated.
Results: A total of 9788 patients (71.5  5.6 years of
age) were screened for an AAA over a 5 year period from
January 1, 2007 to December 31, 2011. A total of 698
aneurysms (7.1%) were found (See Table). Timely referrals
were made on 44 patients with aneurysms greater than 5.5
cm. A total of 2828 patients (28.9%) were inappropriately
screened: 421 patients were too young, 2250 patients were
too old, 36 patients were women, and 121 patients without
aneurysms had multiple screenings.
Conclusions: The long implementation of the AAA
screening has allowed greater deviation from Medicare
guidelines that increased the number of inappropriate
screenings, mandating further AAA screening education for
primary care providers.
Author Disclosures: K. Chun, Nothing to disclose; K.
Teng, Nothing to disclose; E. Van Spyk, Nothing to
disclose; J. Carson, Nothing to disclose; E. Lee, Nothing
to disclose.
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